Fang-Fang Yin
Fang-Fang Yin | |
|---|---|
| Known for | Contributions to radiation therapy |
| Scientific career | |
| Fields | Radiation Oncology |
| Institutions | Duke University |
Fang-Fang Yin is a prominent figure in the field of radiation oncology, known for her extensive research and development in radiation therapy techniques. She has made significant contributions to the treatment of cancer through her work on advanced radiation delivery systems and has held a notable position at Duke University.
Biography[edit | edit source]
The details of Fang-Fang Yin's early life, including her birth date and place, are not widely documented. She pursued higher education in a field related to medical physics or radiation oncology, which laid the foundation for her future career in medical science.
Career[edit | edit source]
Fang-Fang Yin has been associated with Duke University, where she has been instrumental in advancing the field of radiation oncology. Her research primarily focuses on optimizing radiation therapy to improve the efficacy of cancer treatment while minimizing the side effects to patients. Her work often involves the development and refinement of techniques such as intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT).
Contributions[edit | edit source]
Yin's contributions to medical science include numerous publications and presentations on the subject of radiation therapy. She has been involved in various clinical trials and research projects that aim to enhance the precision of radiation doses delivered to tumor sites, thereby improving patient outcomes.
Awards and Recognition[edit | edit source]
Throughout her career, Fang-Fang Yin has received several accolades for her contributions to radiation oncology. The specific awards and honors can be detailed here if known.
See Also[edit | edit source]
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
